Article
The "duty to warn" a patient's family members about hereditary disease risks.
JAMA - 22 Sept 2004
Offit Kenneth, Groeger Elizabeth, Turner Sam, Wadsworth Eve A, Weiser Mary A
Abstract excerpt
Genetic tests for adult-onset disorders, including common forms of cancer, are now commercially available, and tests for genetic polymorphisms that predict drug effects or toxicity after treatment are under development. For each of these circumstances, testing of 1 individual may imply an increased risk to his/her relative. The obligation, if any, to warn family members of the identification of a genetic mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
